Background: There has been a remarkable rise in the worldwide frequency of dengue in recent decades owing to the ineffectiveness of existing management methods including vaccinations and pesticides. Objective: To assess the demographic, clinical and hematological parameters of patients infected with severe and non severe dengue Methodology: This cross sectional study was carried out at the Medicine department, Khalifa Gul Nawaz Teaching Hospital, Bannu Medical College Bannu from May 2022 to October 2022. All the data like demographic, clinical and data related to hematological parameters was recorded on pre-designed Performa. The data was analyzed using SPSS 23. Results: In the current study, totally 180 patients were enrolled. The patients were categorized into NSDI and SD1 group. There were 96 (67.8%) males and 46 (32.4%) females’ patients in NSDI group while there were 28 (73.7%) males and 10 (26.3%) females in SD1 group. Fever was observed in 138 (97.2%) patients in NSDI group and 38 (100%) patients in SDI group. Platelet transfusion was needed in 55 (38.7%) patients in NSDI group while it was needed in 26 (68.4%) patients in SDI group. The mean ±SD Platelet Count x 103mm3 was 39 ±52.5 in NSDI group and 31.5±67.6 in SDI group. The mean ±SD Lowest Platelet Count x 103 mm3 was 28±42 and 21.5± 17 in NSDI group and SDI group respectively. The mean ±SD HCT % was 40.8± 6.7 in NSDI group and 36.0± 12.1 in SDI group. The mean ±SD Leukocytes Count x 103 mm3 was 4400±5425 and 8050±9350 in NSDI group and SDI group respectively. Conclusion: The key to treating and predicting dengue as severe and non-severe cases is to be aware of clinical aspects as well as test results such hematological parameters. Keywords: Demographic, clinical and hematological parameters, severe and non severe dengue infection
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.